Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and

Rachel Huxley1, Sarah Lewington, Robert Clarke

  • 1Department of Public Health Sciences, University of Oxford, Oxford, England.

Insights

Lowering blood cholesterol, particularly LDL cholesterol, significantly reduces coronary heart disease (CHD) risk. This benefit is continuous, with no safe lower threshold, and is more pronounced in individuals with higher overall cardiovascular risk.

Area of Science:

  • Cardiovascular Epidemiology
  • Nutritional Science
  • Clinical Trials

Background:

  • Observational studies show a continuous inverse relationship between blood cholesterol and coronary heart disease (CHD) risk across normal ranges.
  • A 1 mmol/l difference in total cholesterol is linked to a one-third reduction in middle-aged CHD mortality.
  • No cholesterol threshold exists below which lower levels do not reduce risk.

Purpose of the Study:

  • To analyze the relationship between blood cholesterol levels and CHD risk.
  • To evaluate the effectiveness and safety of cholesterol-lowering interventions.
  • To identify factors influencing the benefits of cholesterol reduction.

Main Methods:

  • Analysis of observational epidemiologic studies on cholesterol and CHD risk.
  • Review of large-scale cholesterol-lowering clinical trials in high-risk patients.
  • Examination of the composition of blood cholesterol (LDL and HDL) and its impact on vascular risk.

Main Results:

  • Lowering LDL cholesterol by 1 mmol/l may reduce CHD risk by 40-50%.
  • Cholesterol-lowering trials confirm epidemiologically predicted risk reductions without increasing non-CHD mortality.
  • Benefits of LDL cholesterol reduction are greater in individuals with higher absolute CHD risk.

Conclusions:

  • Dietary saturated fat is a primary driver of total and LDL cholesterol levels.
  • Dietary modifications, such as replacing saturated fats, can significantly lower cholesterol.
  • Targeting LDL cholesterol reduction is crucial for managing cardiovascular risk, especially in high-risk populations.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...